Coppell Advisory Solutions’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-190
| Closed | -$26K | – | 1299 |
|
|
2024
Q4 | $26K | Sell |
190
-247
| -57% | -$33.9K | ﹤0.01% | 777 |
|
|
2024
Q3 | $50.3K | Buy |
437
+247
| +130% | +$28.4K | 0.01% | 550 |
|
|
2024
Q2 | $26.2K | Buy |
+190
| New | +$26.2K | ﹤0.01% | 683 |
|
|
2023
Q4 | $27.1K | Sell |
206
-217
| -51% | -$28.6K | 0.01% | 647 |
|
|
2023
Q3 | $50.5K | Buy |
+423
| New | +$50.5K | 0.02% | 295 |
|
|
2023
Q1 | – | Sell |
-423
| Closed | -$50.5K | – | 752 |
|
|
2022
Q4 | $50.5K | Buy |
+423
| New | +$50.5K | 0.02% | 296 |
|